Senior Product Manager - B2B2C
About the job
- A proven track record of 5+ years in product management roles within fast-paced, growth-oriented environments.
- Demonstrated success developing consumer products from concept through launch, including defining product strategy and working under tight deadlines.
- Strong analytical skills and experience with data-driven decision-making, combining intuition with research.
- Experience conducting user experience research (UXR) and translating user insights into product strategy.
- Proficiency with A/B testing, experimentation, and iterative product development methodologies.
- Experience influencing cross-functional stakeholders through communication and collaboration.
- Conduct user experience research and market validation to test strategy assumptions and define product-market fit.
- Lead product launch execution and initial go-to-market rollout.
- Develop and execute growth strategies to drive user acquisition, engagement, and retention throughout the product lifecycle.
- Drive product development in partnership with engineering, design, data science, and analytics teams.
- Design and test service prototypes in collaboration with clinical, product, and go-to-market teams, focusing on speed-to-learning.
- Work closely with Sales, Customer Success, and Clinical teams to understand customer needs and commercial viability.
- Partner with the commercial team to validate market demand and ensure product-market fit before major investment.
- Establish metrics for success and health checks that inform go/no-go decisions at key milestones.
- Experience in healthcare, digital health, or B2B2C product environments.
- Track record launching or scaling products in adjacent markets or new product lines.
- A BS or MS in Engineering, Computer Science, Mathematics, Physics, Statistics, or a related quantitative field.
- Experience in a high-growth, resource-constrained environment.
About the company
Hello Heart provides a digital therapeutics program for cardiovascular health that includes a free blood pressure monitor and a mobile app to track heart metrics and manage conditions, offered through employers and health plans as a covered benefit (B2B2C). The product connects a blood pressure monitor to the app, allowing users to track blood pressure, cholesterol, and medications, with personalized health insights and coaching informed by behavioral science. It stands out by combining medical hardware with targeted cardiovascular care and coaching, delivered through a scalable employer-sponsored model focused on prevention and reducing costs for employers. The goal is to improve population heart health while lowering healthcare expenses by preventing and better managing chronic cardiovascular conditions through technology, monitoring hardware, and behavioral coaching.
Company Size
501-1,000
Company Stage
Series D
Total Funding
$138M
Headquarters
Menlo Park, California
Founded
2013
Get referred to Hello Heart
See people who can refer or advise you
Simplify's Take
What believers are saying
- May 2026 Circulation study found higher enrollment among lower-income members and fewer ED visits.
- August 2026 heart-failure study reported $7,001 lower medical spend and fewer hospitalizations.
- October 2025 Nia launch deepens engagement, extending coach-like support between clinician visits.
What critics are saying
- Employer ROI proof still depends on self-reported savings and usage, weakening renewal leverage.
- Category incumbents like CVS, Aetna, and digital point-solution platforms can bundle away differentiation.
- If ACC validation fails or outcomes disappoint, health-plan adoption and valuations compress fast.
What makes Hello Heart unique
- Hello Heart combines connected monitors, app coaching, and medication support in one workflow.
- ACC collaboration in March 2026 validates clinical credibility and EMR integration ambitions.
- Navitus distribution in September 2025 expands access through PBM contracting and billing.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Wellness Program
Remote Work Options
Flexible Work Hours
401(k) Retirement Plan
401(k) Company Match
Professional Development Budget
Conference Attendance Budget
Stock Options
Company Equity
Paid Vacation
Paid Sick Leave
Paid Holidays
Sabbatical Leave
Parental Leave
Family Planning Benefits
Fertility Treatment Support
Adoption Assistance
Childcare Support
Elder Care Support
Mental Health Support
Gym Membership
Phone/Internet Stipend
Home Office Stipend
Growth & Insights and Company News
6 month growth
0%1 year growth
0%2 year growth
0%Hello Heart, an AI-powered preventive heart health company, has appointed Charles MacGlashing as Chief Financial Officer. MacGlashing joins from HubSpot, where he spent over a decade, most recently as Senior Vice President of Treasury, Corporate Development, and Investor Relations. The appointment follows strong growth for Hello Heart, which increased committed annual recurring revenue by 50% in 2025 and expects comparable growth in 2026. The company's AI platform identifies cardiovascular risk earlier than traditional methods, detecting elevated near-term risk up to 90 days in advance. MacGlashing brings more than 20 years of experience across finance and capital markets. He will lead Hello Heart's finance organisation and contribute to corporate strategy as the company expands across employers, health plans, and public sector organisations.
The company’s flagship app helps patients manage their heart health by tracking their blood pressure, medications and activity using AI technology.
Hello Heart raised $45 million from growth equity firm IVP. It plans to use the funds to build up its platform as it goes toe-to-toe with large competitors in chronic disease management.
Hello Heart develops a device that tests blood pressure and blood sugar levels and helps patients monitor their health, drug intake, and physical exercise through a dedicated mobile app